Tower Research Capital LLC (Trc) Pro Qr Therapeutics N.V. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.65 - $2.39 $1,354 - $1,962	821 New	821 $1,000
Q4 2023 Feb 13, 2024	BUY	$1.15 - $2.21 $4,066 - $7,814	3,536 New	3,536 $7,000
Q1 2023 May 09, 2023	BUY	$1.99 - $3.66 $17,504 - $32,193	8,796 Added 164.84%	14,132 $30,000
Q4 2022 Feb 10, 2023	SELL	$0.8 - $3.7 $6,350 - $29,370	-7,938 Reduced 59.8%	5,336 $20,000
Q3 2022 Nov 10, 2022	SELL	$0.74 - $0.89 $3,613 - $4,345	-4,883 Reduced 26.89%	13,274 $10,000
Q2 2022 Aug 15, 2022	BUY	$0.56 - $1.0 $8,901 - $15,895	15,895 Added 702.7%	18,157 $14,000
Q1 2022 May 12, 2022	BUY	$0.9 - $8.39 $295 - $2,751	328 Added 16.96%	2,262 $2,000
Q4 2021 Feb 14, 2022	BUY	$6.58 - $8.44 $12,725 - $16,322	1,934 New	1,934 $16,000
Q2 2021 Aug 16, 2021	SELL	$5.75 - $7.59 $89,964 - $118,753	-15,646 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.14 - $9.22 $63,946 - $142,412	15,446 Added 7723.0%	15,646 $103,000
Q4 2020 Feb 16, 2021	SELL	$3.58 - $4.85 $31,357 - $42,481	-8,759 Reduced 97.77%	200 $1,000
Q3 2020 Nov 16, 2020	BUY	$4.79 - $6.3 $36,590 - $48,125	7,639 Added 578.71%	8,959 $43,000
Q2 2020 Aug 13, 2020	BUY	$4.5 - $6.53 $4,554 - $6,608	1,012 Added 328.57%	1,320 $8,000
Q1 2020 May 15, 2020	SELL	$5.25 - $9.9 $19,766 - $37,273	-3,765 Reduced 92.44%	308 $2,000
Q4 2019 Feb 07, 2020	BUY	$5.84 - $10.51 $23,786 - $42,807	4,073 New	4,073 $40,000
Q3 2019 Nov 05, 2019	SELL	$5.76 - $9.44 $49,806 - $81,627	-8,647 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$9.1 - $15.55 $78,687 - $134,460	8,647 New	8,647 $79,000
Q1 2019 May 14, 2019	SELL	$12.5 - $18.48 $6,987 - $10,330	-559 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$15.25 - $22.4 $6,298 - $9,251	413 Added 282.88%	559 $9,000
Q3 2018 Nov 13, 2018	BUY	$6.45 - $21.6 $941 - $3,153	146 New	146 $3,000
Q2 2018 Aug 15, 2018	SELL	$2.95 - $7.45 $4,690 - $11,845	-1,590 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$2.9 - $3.5 $1,986 - $2,397	-685 Reduced 30.11%	1,590 $5,000
Q4 2017 Feb 09, 2018	SELL	$2.8 - $4.8 $1,859 - $3,187	-664 Reduced 22.59%	2,275 $7,000
Q3 2017 Nov 14, 2017	BUY	$4.35 - $6.45 $12,784 - $18,956	2,939	2,939 $14,000

Others Institutions Holding PRQR

# of Institutions

Shares Held

17.4M

Call Options Held

37.7K

Put Options Held

21.3K

Privium Fund Management B.V.

5.63M
Shares

$15 Million
2.56% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

3.63M
Shares

$9.68 Million
0.01% of portfolio
Eco R1 Capital, LLC San Francisco, CA

1.84M
Shares

$4.9 Million
0.14% of portfolio
M28 Capital Management LP Stamford, CT

1.02M
Shares

$2.72 Million
1.76% of portfolio
Dafna Capital Management LLC Los Angeles, CA

906K
Shares

$2.42 Million
0.42% of portfolio

View Full List

About ProQR Therapeutics N.V.

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $191M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

More about PRQR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account